May 14, 2024 · To the annual meeting of Abera Bioscience AB (“Abera” or “the Company”), Harry Råsted is nominated as a new board member. He possesses long experience from the vaccine industry, e.g. as Head of Vaccines GSK Europe.

Abera is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from …

Abera Bioscience is developing the next generation mucosal vaccines based on our proprietary vaccine delivery platform. With the novel vaccine platform BERA, Abera can decorate Outer Membrane Vesicles (OMVs) with large amounts of antigen of one or more varieties.

We are incredible happy and proud to be able to welcome Ann-Christin Magnusson to Abera team as Lab Manager for our newly established lab in Sweden.

May 14, 2024 · Abera besitter flera egenutvecklade och patenterade plattformsteknologier som möjliggör effektiv utveckling av vaccinkandidater med fleratalet fördelar jämfört med befintliga vacciner, bland annat möjligheten att ge vaccin som nässpray.

Apr 24, 2022 · Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

Jul 10, 2023 · The board of Abera has decided to put the more mature projects into separate subsidiaries to facilitate financing by making the various companies more attractive to investors with different interests and investment profiles, it states in a press release.

Feb 2, 2021 · Abera Bioscience AB is a Swedish vaccine and biotechnology company developing vaccines based on their patented platform technology.

Abera Bioscience is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from the Swedish protein production company Xbrane Bioscience.

"Abera is a Swedish biotech company committed to becoming a world-leading company in innovative vaccine technologies. Abera has developed a unique vaccine platform based on Gram-negative bacteria and derived Outer Membrane Vesicles (OMVs) that can be decorated on the surface with multiple antigens of choice at a high density.